Nour AlSaleh is the Founder and Chief Executive Officer of VERAGENCE Pharmaceutical Consultation Company, bringing more than 20 years of experience in the pharmaceutical industry across the Middle East.

A highly accomplished pharmaceutical quality professional, Nour holds a Bachelor’s degree in Pharmacy and a Master of Business Administration (MBA) with a specialization in Quality Management. Throughout her career, she has held senior leadership positions in Quality Assurance, Quality Compliance, Quality Control, and Validation within leading regional and multinational pharmaceutical organizations, including Hikma Pharmaceuticals, MS Pharma, and Dar Al Dawa.

Nour has extensive expertise in pharmaceutical quality systems and regulatory compliance, with a proven track record of leading organizations through inspections conducted by major regulatory authorities, including the U.S. Food and Drug Administration, Saudi Food and Drug Authority, Jordan Food and Drug Administration, Health Products Regulatory Authority, and other GCC and European regulatory agencies.

Her areas of expertise include Quality Management Systems, Operational Quality Compliance, Quality Risk Management, Internal and External Auditing, Contract Manufacturing Due Diligence and Assessments, Quality Investigations, Validation, and Product Lifecycle Management. Through VERAGENCE, Nour supports pharmaceutical organizations in strengthening quality culture, ensuring regulatory compliance, and achieving sustainable operational excellence.

Recognized for her strategic leadership and deep technical expertise, Nour is committed to helping organizations navigate complex regulatory environments while driving continuous improvement and business performance.